IL32 and metabolic dysfunction-associated steatotic liver disease: Interestingly, hepatic IL-32 was found to correlate with circulating IL-32, which may render IL-32 a candidate molecule to be investigated for the non-invasive assessment of MASLD presence and/or severity [74].